Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)

A biosimilar is a biological medicinal product that contains a version of the active substance of an already authorized original biological medicinal product. Biosimilarity to the reference product (RP) in terms of quality characteristics, such as physicochemical and biological properties, safety, a...

Full description

Bibliographic Details

Published in:	mAbs Vol. 9; no. 2; pp. 364 - 383
Main Authors:	Hong, Juyong, Lee, Yuhwa, Lee, Changsoo, Eo, Suhyeon, Kim, Soyeon, Lee, Nayoung, Park, Jongmin, Park, Seungkyu, Seo, Donghyuck, Jeong, Min, Lee, Youngji, Yeon, Soojeong, Bou-Assaf, George, Sosic, Zoran, Zhang, Wei, Jaquez, Orlando
Format:	Journal Article
Language:	English
Published:	United States Taylor & Francis 17-02-2017
Subjects:	Animals Biosimilar Pharmaceuticals - chemistry Biosimilar Pharmaceuticals - pharmacology Humans Infliximab - chemistry Infliximab - pharmacology SB2 renflexis critical quality attribute flixabi infliximab Biosimilar
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!